Implants of Tenofovir Alafenamide Could Provide Protection for 6 Months, Study Says
April 12th 2019Subcutaneous implants are 1 promising strategy to address suboptimal adherence to pre-exposure prophylaxis (PrEP) for HIV, and a recent in silico simulation examined pharmacokinetic profiles and safety of tenofovir alafenamide implants.
William Schaffner, MD, Shares Highlights From NFID Annual Conference on Vaccinology Research
April 5th 2019Contagion® caught up with William Schaffner, MD, medical director of the National Foundation for Infectious Diseases, to discuss the highlights from this week’s NFID Annual Conference on Vaccinology Research.